14:58:18 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2025-02-14 Bokslutskommuniké 2024
2024-11-14 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-17 Kvartalsrapport 2024-Q1
2024-03-01 Ordinarie utdelning CSMED 0.00 DKK
2024-02-29 Årsstämma 2024
2024-02-14 Bokslutskommuniké 2023
2023-12-15 Ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma 2023
2023-02-10 Ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 Ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021


ListaSpotlight DK
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2022-05-20 16:29:23

CS MEDICA A/S ("CS MEDICA" or the "Company") was  chosen to Vitafoods Europe 2022 Innovation Tours at the Vitafoods Europe 2022 trade fair the 10-12 May 2022. CS MEDICA's fully owned subsidiary CanNordic a/s represented the Company and showcased the CANNASEN ®CBD product line with the purpose to target new distributor agreements.

"We were proud to be selected to showcase our unique and innovative products at the Vitafoods event. We feel that our products were highlighted especially as our products represented the only medical device brand with products containing CBD. We engaged in several interesting discussions, and we found our participation very productive, especially with the global presence of different partners," comments CEO Lone Henriksen.

At the trade fair, CanNordic was nominated as one of the most innovative companies with unique, groundbreaking ingredients, formulations and products and hence took part in the Innovation Tour 2022.  Further, CanNordic was part of the "New Product" category and participated at the live stage Vitafoods Europe 2022 new product presentations. The presentation of the CANNASEN ® CBD line, presented by CEO Lone Henriksen, was recorded on video by the live stage content team. The video is attached in this press release and can also be viewed here (https://streamable.com/odghuj).

[image] [image] [image]

The trade fair exceeded all expectations.  The trade fair stand got an unsurpassed attention which was accomplished by overwhelmingly positive responses, few of them rendered below;

"We met at the Vitafoods expo in Geneva. Thank you for your hospitality, your samples and the information you provided on our visit. During the meeting I mentioned I would like to try the Arthritis Gel myself, because of the pain caused by knee arthritis. I have to admit the product works very well even after the first use. The pain in my knee completely disappeared plus it provides a nice cooling effect", comments Boris Blazic from NaturaMedica d.o.o.

"In an industry filled with hundreds of products with no clinical backing, it is extremely refreshing to see CANNASEN's focus on clinical studies and data. Based on our experience, only the clinically-backed products survive over a long time frame and CANNASEN's focus on clinically-backed CBD products clearly sets them apart from the majority of the industry", comments Varun Rungta from GCCPL India (one of the BIG Pharma companies in India).